Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins.

Hsu CH, Chan D, Wolozin B.

Neurodegener Dis. 2010;7(1-3):68-75. doi: 10.1159/000285509. Epub 2010 Feb 18.

2.
3.

MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2.

Hsu CH, Chan D, Greggio E, Saha S, Guillily MD, Ferree A, Raghavan K, Shen GC, Segal L, Ryu H, Cookson MR, Wolozin B.

J Neurochem. 2010 Mar;112(6):1593-604. doi: 10.1111/j.1471-4159.2010.06568.x. Epub 2010 Jan 7.

5.

JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.

Ito M, Yoshioka K, Akechi M, Yamashita S, Takamatsu N, Sugiyama K, Hibi M, Nakabeppu Y, Shiba T, Yamamoto KI.

Mol Cell Biol. 1999 Nov;19(11):7539-48.

6.

The JIP group of mitogen-activated protein kinase scaffold proteins.

Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ.

Mol Cell Biol. 1999 Oct;19(10):7245-54.

7.

Reverse two-hybrid screening identifies residues of JNK required for interaction with the kinase interaction motif of JNK-interacting protein-1.

Barr RK, Hopkins RM, Watt PM, Bogoyevitch MA.

J Biol Chem. 2004 Oct 8;279(41):43178-89. Epub 2004 Jul 22.

8.

Regulation of stress-associated scaffold proteins JIP1 and JIP3 on the c-Jun NH2-terminal kinase in ischemia-reperfusion.

Xu B, Zhou Y, O K, Choy PC, Pierce GN, Siow YL.

Can J Physiol Pharmacol. 2010 Nov;88(11):1084-92. doi: 10.1139/y10-088.

PMID:
21076496
9.

Reassembly of JIP1 scaffold complex in JNK MAP kinase pathway using heterologous protein interactions.

Moon J, Park SH.

PLoS One. 2014 May 9;9(5):e96797. doi: 10.1371/journal.pone.0096797. eCollection 2014.

10.

The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.

Gloeckner CJ, Schumacher A, Boldt K, Ueffing M.

J Neurochem. 2009 May;109(4):959-68. doi: 10.1111/j.1471-4159.2009.06024.x. Epub 2009 Mar 3.

11.

Rap1 is involved in cell stretching modulation of p38 but not ERK or JNK MAP kinase.

Sawada Y, Nakamura K, Doi K, Takeda K, Tobiume K, Saitoh M, Morita K, Komuro I, De Vos K, Sheetz M, Ichijo H.

J Cell Sci. 2001 Mar;114(Pt 6):1221-7.

12.

Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1.

Blanco S, Santos C, Lazo PA.

Mol Cell Biol. 2007 Oct;27(20):7273-83. Epub 2007 Aug 20.

13.

Stress-activated kinase pathway alteration is a frequent event in bladder cancer.

Otto KB, Acharya SS, Robinson VL.

Urol Oncol. 2012 Jul-Aug;30(4):415-20. doi: 10.1016/j.urolonc.2010.03.002. Epub 2011 Dec 11.

PMID:
22154358
14.

c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.

Sprowles A, Robinson D, Wu YM, Kung HJ, Wisdom R.

Exp Cell Res. 2005 Aug 15;308(2):459-68.

PMID:
15950217
15.

Differential regulation of M3/6 (DUSP8) signaling complexes in response to arsenite-induced oxidative stress.

Oehrl W, Cotsiki M, Panayotou G.

Cell Signal. 2013 Feb;25(2):429-38. doi: 10.1016/j.cellsig.2012.11.010. Epub 2012 Nov 15.

PMID:
23159405
17.

Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein.

Blanco S, Sanz-GarcĂ­a M, Santos CR, Lazo PA.

PLoS One. 2008 Feb 20;3(2):e1660. doi: 10.1371/journal.pone.0001660.

18.

alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells.

Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E.

J Biol Chem. 2002 Mar 29;277(13):11465-72. Epub 2002 Jan 14.

19.
20.

Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes.

Kietzmann T, Samoylenko A, Immenschuh S.

J Biol Chem. 2003 May 16;278(20):17927-36. Epub 2003 Mar 11.

Items per page

Supplemental Content

Write to the Help Desk